Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

TNF signaling drives myeloid-derived suppressor cell accumulation
Xueqiang Zhao, … , Joachim Sieper, Zhihai Qin
Xueqiang Zhao, … , Joachim Sieper, Zhihai Qin
Published October 15, 2012
Citation Information: J Clin Invest. 2012;122(11):4094-4104. https://doi.org/10.1172/JCI64115.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 19

TNF signaling drives myeloid-derived suppressor cell accumulation

  • Text
  • PDF
Abstract

TNF, an inflammatory cytokine that is enriched in the tumor microenvironment, promotes tumor growth and subverts innate immune responses to cancer cells. We previously reported that tumors implanted in TNF receptor–deficient (Tnfr–/–) mice are spontaneously rejected; however, the molecular mechanisms underlying this rejection are unclear. Here we report that TNF signaling drives the peripheral accumulation of myeloid-derived suppressor cells (MDSCs). MDSCs expand extensively during inflammation and tumor progression in mice and humans and can enhance tumor growth by repressing T cell–mediated antitumor responses. Peripheral accumulation of MDSCs was drastically impaired in Tnfr–/– mice. Signaling of TNFR-2, but not TNFR-1, promoted MDSC survival through upregulation of cellular FLICE-inhibitory protein (c-FLIP) and inhibition of caspase-8 activity. Loss of TNFRs impaired the induction of MDSCs from bone marrow cells, but this could be reversed by treatment with caspase inhibitors. These results demonstrate that TNFR-2 signaling promotes MDSC survival and accumulation and helps tumor cells evade the immune system.

Authors

Xueqiang Zhao, Lijie Rong, Xiaopu Zhao, Xiao Li, Xiaoman Liu, Jingjing Deng, Hao Wu, Xia Xu, Ulrike Erben, Peihua Wu, Uta Syrbe, Joachim Sieper, Zhihai Qin

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2009 Total
Citations: 5 20 14 26 29 19 14 24 21 16 12 12 7 1 220
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (220)

Title and authors Publication Year
Inflammation and cancer cell survival: TRAF2 as a key player
Albini A, Di Paola L, Mei G, Baci D, Fusco N, Corso G, Noonan D
Cell Death & Disease 2025
Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma
Chivite\u2010Lacaba M, Justo I, Utrero\u2010Rico A, Caso O, González\u2010Cuadrado C, Del Rey MJ, Laguna\u2010Goya R, Arroyo\u2010Ródenas J, Alfocea\u2010Molina Á, Ruigómez\u2010Martín CC, Serrano M, Pascual\u2010Palacios L, Mancebo ME, Paz\u2010Artal E
International Journal of Cancer 2025
Immunocytes in the tumor microenvironment: recent updates and interconnections
Yu J, Fu L, Wu R, Che L, Liu G, Ran Q, Xia Z, Liang X, Zhao G
Frontiers in Immunology 2025
Myeloid cells: key players in tumor microenvironments.
Hua Q, Li Z, Weng Y, Wu Y, Zheng L
Frontiers of medicine 2025
The Role of TNF-α in Neuropathic Pain: An Immunotherapeutic Perspective
García-Domínguez M
Life 2025
ΔNp63 regulates MDSC survival and metabolism in triple-negative breast cancer
Kim U, Debnath R, Maiz JE, Rico J, Sinha S, Blanco MA, Chakrabarti R
iScience 2024
Coagulation Protease-Driven Cancer Immune Evasion: Potential Targets for Cancer Immunotherapy.
Paul S, Mukherjee T, Das K
Cancers 2024
Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions
Toffoli EC, van Vliet AA, Forbes C, Arns AJ, Verheul HW, Tuynman J, van der Vliet HJ, Spanholtz J, de Gruijl TD
Clinical & Experimental Immunology 2024
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y
Journal of Hematology & Oncology 2024
Sequential immunotherapy: towards cures for autoimmunity.
Ramírez-Valle F, Maranville JC, Roy S, Plenge RM
Nature reviews. Drug discovery 2024
Hyperexpression of tumor necrosis factor receptor 2 inhibits differentiation of myeloid‐derived suppressor cells by instigating apolarity during ageing
Wang M, Han Y, Yao X, Duan X, Wan J, Lou X, Yan Y, Zheng P, Wang F, Zhu L, Ni C, Pan Z, Wang Z, Chen L, Wang Z, Qin Z
MedComm 2024
Impact of obesity-associated myeloid-derived suppressor cells on cancer risk and progression (Review)
Jiménez-Cortegana C, Gutiérrez-García C, Sánchez-Jiménez F, Vilariño-García T, Flores-Campos R, Pérez-Pérez A, Garnacho C, Sánchez-León ML, García-Domínguez DJ, Hontecillas-Prieto L, Palazón-Carrión N, De La Cruz-Merino L, Sánchez-Margalet V
International journal of oncology 2024
Targeting cytokine and chemokine signaling pathways for cancer therapy.
Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z
Signal Transduction and Targeted Therapy 2024
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.
Luo Y, Lu J, Lei Z, Zhu H, Rao D, Wang T, Fu C, Zhang Z, Xia L, Huang W
Biomarker Research 2024
Tumor necrosis factor regulates leukocyte recruitment but not bacterial persistence during Staphylococcus aureus craniotomy infection
Van Roy Z, Kielian T
Journal of Neuroinflammation 2024
Targeting TNFR2 for cancer immunotherapy: recent advances and future directions
Li L, Ye R, Li Y, Pan H, Han S, Lu Y
Journal of Translational Medicine 2024
The multifaceted role of the stroma in the healthy prostate and prostate cancer.
Di Carlo E, Sorrentino C
Journal of translational medicine 2024
VSIG-3/IGSF11 silencing in A2058 melanoma cells simultaneously suppresses melanoma progression and induces anti-tumoral cytokine profile in human T cells: In silico and in vitro study.
Shekari N, Shanehbandi D, Baghbani E, Safaei S, Masoumi J, Baradaran B, Jalali SA
Naunyn-Schmiedeberg's archives of pharmacology 2024
Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms
Wu Y, Sun X, Kang K, Yang Y, Li H, Zhao A, Niu T
Journal of Hematology & Oncology 2024
TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.
Debesset A, Pilon C, Meunier S, Cuelenaere-Bonizec O, Richer W, Thiolat A, Houppe C, Ponzo M, Magnan J, Caron J, Caudana P, Tosello Boari J, Baulande S, To NH, Salomon BL, Piaggio E, Cascone I, Cohen JL
Journal for immunotherapy of cancer 2024
Single-cell profiling reveals a conserved role for hypoxia-inducible factor signaling during human craniotomy infection
Van Roy Z, Kak G, Korshoj LE, Menousek JP, Heim CE, Fallet RW, Campbell JR, Geary CR, Liu B, Gorantla S, Poluektova LY, Duan B, Campbell WS, Thorell WE, Kielian T
Cell Reports Medicine 2024
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer
Mussa A, Ismail NH, Hamid M, Al-Hatamleh MA, Bragoli A, Hajissa K, Mokhtar NF, Mohamud R, Uskoković V, Hassan R
Journal of Experimental & Clinical Cancer Research : CR 2024
Melanoma in people living with HIV: Immune landscape dynamics and the role of immuno- and antiviral therapies
Barger LN, El Naggar OS, Ha B, Romano G
Cancer Metastasis Reviews 2024
Acute remote ischemic conditioning enhances (CD3+)- but not (FoxP3+)-T-cell invasion in the tumor center and increases IL 17 and TNF-alpha expression in a murine melanoma model
Rachunek-Medved K, Krauß S, Daigeler A, Adams C, Eckert F, Ganser K, Gonzalez-Menendez I, Quintanilla-Martinez L, Kolbenschlag J
Frontiers in Immunology 2024
In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors
Kang X, Han Y, Wu M, Li Y, Qian P, Xu C, Zou Z, Dong J, Wei J
Molecular Therapy 2024
Intercellular HIF1a reprogams mammary progenitors and myeloid immune evasion to drive high-risk breast lesions
Irene Bertolini, Michela Perego, Yulia Nefedova, Cindy Lin, Andrew T Milcarek, Peter Vogel, Jagadish Ghosh, Andrew Kossenkov, Dario Altieri
Journal of Clinical Investigation 2023
The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment.
Mohd Salim NH, Mussa A, Ahmed N, Ahmad S, Yean Yean C, Hassan R, Uskoković V, Mohamud R, Che Jalil NA
Biomedicines 2023
The Effective Components, Core Targets, and Key Pathways of Ginseng against Alzheimer's Disease
Wang Y, Liu X
Evidence-based complementary and alternative medicine : eCAM 2023
TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments
Liao P, Jiang M, Islam MS, Wang Y, Chen X
Frontiers in immunology 2023
5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity
Yang Y, Zhang M, Zhang Y, Liu K, Lu C
Cancers 2023
Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
Zhong Y, Li F, Zhang S, Yang Z, Ren X, Cao X, Xu Y, Guo D, Zhou Y, Mao F, Shen S, Sun Q
Cancer Cell International 2023
Skeletal muscle mass and quality before preoperative chemotherapy influence postoperative long-term outcomes in esophageal squamous cell carcinoma patients
Ichinohe D, Muroya T, Akasaka H, Hakamada K
World journal of gastrointestinal surgery 2023
Optimum fractionation of radiation to combine PD‐1 blockade
Teng F, Yin T, Ju X, Wang P, Wang Y, Yu J
2023
Accelerating the Evolution of Immune-Related Enterocolitis Management
Faleck DM, Dougan M, Tello M, Grossman JE, Moss AC, Postow MA
Journal of Clinical Oncology 2023
The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma.
Koelsch N, Mirshahi F, Aqbi HF, Saneshaw M, Idowu MO, Olex AL, Sanyal AJ, Manjili MH
Scientific Reports 2023
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond.
Siegmund D, Wajant H
Nature reviews. Rheumatology 2023
Therapeutic potential of TNFR2 agonists: a mechanistic perspective
Chen Y, Jiang M, Chen X
Frontiers in immunology 2023
PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
Qiao H, Li H
Pharmacogenomics and Personalized Medicine 2023
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
Vachliotis ID, Valsamidis I, Polyzos SA
Cancers 2023
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation
A Moatti, A Debesset, C Pilon, A Beldi-Ferchiou, M Leclerc, R Redjoul, F Charlotte, N To, A Bak, Y Belkacemi, B Salomon, F Issa, D Michonneau, S Maury, J Cohen, A Thiolat
Journal for ImmunoTherapy of Cancer 2022
Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
X Zhang, M Lao, J Xu, Y Duan, H Yang, M Li, H Ying, L He, K Sun, C Guo, W Chen, H Jiang, X Zhang, X Bai, T Liang
Journal for ImmunoTherapy of Cancer 2022
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
A Bleve, F Consonni, C Porta, V Garlatti, A Sica
Cancers 2022
Interaction of Immune and Cancer Cells
M Klink, I Szulc-Kielbik
2022
The proprotein convertase furin in cancer: more than an oncogene
Z He, A Khatib, J Creemers
Oncogene 2022
Role of fibrosarcoma-induced CD11b+ myeloid cells and tumor necrosis factor-α in B cell responses
Z Wang, Y Liu, L Peng, B Till, Y Liao, S Yuan, X Yan, L Chen, Q Fu, Z Qin
Oncogene 2022
Mannan-Binding Lectin Deficiency Limits Inflammation-induced Myeloid-Derived Suppressor Cells Expansion via Modulating Tumor Necrosis Factor Alpha-triggered Apoptosis
L Dong, H Jiang, K Chen, J Xie, Q An, F Deng, Z Sun, Y Liu, J Zhou, L Zhang, X Lu, M Wang, Z Chen, X Zou, D Zuo
International journal of biological sciences 2022
Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer
D Plundrich, S Chikhladze, S Fichtner-Feigl, R Feuerstein, P Briquez
International journal of molecular sciences 2022
Mechanism of Herb Pairs Astragalus mongholicus and Curcuma phaeocaulis Valeton in Treating Gastric Carcinoma: A Network Pharmacology Combines with Differential Analysis and Molecular Docking
Z Wu, X Pan, C Deng, M Cai, K Yuan, P Huang, G Shi, J Cruz
Evidence-Based Complementary and Alternative Medicine 2022
Elevated circulating myeloid‐derived suppressor cells associated with poor prognosis in B‐cell non‐Hodgkin's lymphoma patients
Y Wang, J Wang, F Zhu, H Wang, L Yi, K Huang, Z Zhai
Immunity, Inflammation and Disease 2022
Effective biomarkers and therapeutic targets of nerve-immunity interaction in the treatment of depression: an integrated investigation of the miRNA-mRNA regulatory networks
Z Wu, Z Cai, H Shi, X Huang, M Cai, K Yuan, P Huang, G Shi, T Yan, Z Li
Aging 2022
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
Medler J, Kucka K, Wajant H
Cancers 2022
The Role of Inflammatory Mediators in Colorectal Cancer Hepatic Metastasis
Goodla L, Xue X
Cells 2022
Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
Li M, Zhang X, Bai X, Liang T
Frontiers in Oncology 2022
The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
Takahashi H, Yoshimatsu G, Faustman DL
Cells 2022
TFNR2 in Ischemia-Reperfusion Injury, Rejection, and Tolerance in Transplantation
Kouyoumdjian A, Tchervenkov J, Paraskevas S
Frontiers in immunology 2022
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy.
Wang Y, Johnson KCC, Gatti-Mays ME, Li Z
Journal of Hematology & Oncology 2022
Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS
Velegraki M, Stiff A, Papadaki HA, Li Z
Journal of Clinical Medicine 2022
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment
Aguilar-Cazares D, Chavez-Dominguez R, Marroquin-Muciño M, Perez-Medina M, Benito-Lopez JJ, Camarena A, Rumbo-Nava U, Lopez-Gonzalez JS
Frontiers in Endocrinology 2022
TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy.
Quazi S
Medical Oncology 2022
The Function and Therapeutic Implications of TNF Signaling in MDSCs.
Yu K, Yu C, Jiao L, Miao K, Ni L, Rao X, Zhou L, Zhao C
Biomolecules 2022
Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker
Kartikasari AE, Cassar E, Razqan MA, Szydzik C, Huertas CS, Mitchell A, Plebanski M
Frontiers in immunology 2022
Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression
Plackoska V, Shaban D, Nijnik A
Frontiers in immunology 2022
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy.
Bhatnagar S, Revuri V, Shah M, Larson P, Shao Z, Yu D, Prabha S, Griffith TS, Ferguson D, Panyam J
Cancers 2022
The Therapeutic Effect of Tacrolimus in a Mouse Psoriatic Model is Associated with the Induction of Myeloid-derived Suppressor Cells
Chen S, Liao P, Xi L, Yang Y, Wu W, Islam MS, Lin Z, Zheng Y, Chen X
2022
A 3D Osteosarcoma Model with Bone-mimicking Cues Reveals a Critical Role of Bone Mineral and Informs Drug Discovery
Díaz EC, Lee AG, Sayles LC, Feria C, Sweet-Cordero EA, Yang F
Advanced Healthcare Materials 2022
T Regulatory Cells in Human Health and Diseases
SG Zheng
2021
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
AK Pullikuth, ED Routh, KD Zimmerman, J Chifman, JW Chou, MH Soike, G Jin, J Su, Q Song, MA Black, C Print, D Bedognetti, M Howard-McNatt, SS ONeill, A Thomas, CD Langefeld, AB Sigalov, Y Lu, LD Miller
Frontiers in Oncology 2021
Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
Y Li, H He, R Jihu, J Zhou, R Zeng, H Yan
Frontiers in Cell and Developmental Biology 2021
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
K Li, H Shi, B Zhang, X Ou, Q Ma, Y Chen, P Shu, D Li, Y Wang
Signal Transduction and Targeted Therapy 2021
An Updated Understanding of the Role of YAP in Driving Oncogenic Responses
G Morciano, B Vezzani, S Missiroli, C Boncompagni, P Pinton, C Giorgi
Cancers 2021
Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled
RV Sionov
Cells 2021
Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth
LM Kreps, CL Addison
International journal of molecular sciences 2021
Insights into the biology and therapeutic implications of TNF and regulatory T cells
BL Salomon
Nature Reviews Rheumatology 2021
TNF in the era of immune checkpoint inhibitors: friend or foe?
AY Chen, JD Wolchok, AR Bass
Nature Reviews Rheumatology 2021
The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response
A Moatti, JL Cohen
Frontiers in Cell and Developmental Biology 2021
TNFR2: Role in Cancer Immunology and Immunotherapy
Y Yang, S Islam, Y Hu, X Chen
ImmunoTargets and Therapy 2021
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
MF Mercogliano, S Bruni, F Mauro, PV Elizalde, R Schillaci
Cancers 2021
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
C Zalfa, S Paust
Frontiers in immunology 2021
Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells
Z Li, Y Zhao, Z Chen, J Katz, SM Michalek, Y Li, P Zhang
Molecular Immunology 2021
Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes
S Wang, Q Tan, Y Hou, H Dou
Frontiers in pharmacology 2021
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
H Zhu, JD Klement, C Lu, PS Redd, D Yang, AD Smith, DB Poschel, J Zou, D Liu, PG Wang, D Ostrov, N Coant, YA Hannun, AH Colby, MW Grinstaff, K Liu
Journal of immunology (Baltimore, Md. : 1950) 2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
JT Brown, Y Liu, JM Shabto, D Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, L Yantorni, SS Joshi, H Kissick, K Ogan, B Nazha, BC Carthon, O Kucuk, WB Harris, VA Master, MA Bilen
Journal for ImmunoTherapy of Cancer 2021
MYO10 drives genomic instability and inflammation in cancer
FM Pozo, X Geng, I Tamagno, MW Jackson, EG Heimsath, JA Hammer, RE Cheney, Y Zhang
Science Advances 2021
Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer
Y Ban, GJ Markowitz, Y Zou, D Ramchandani, J Kraynak, J Sheng, SB Lee, ST Wong, NK Altorki, D Gao, V Mittal
2021
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
E Mortaz, P Tabarsi, H Jamaati, ND Roofchayee, NK Dezfuli, SM Hashemian, A Moniri, M Marjani, M Malekmohammad, D Mansouri, M Varahram, G Folkerts, IM Adcock
Frontiers in immunology 2021
TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?
T Benoot, E Piccioni, KD Ridder, C Goyvaerts
International journal of molecular sciences 2021
The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment
D Laha, R Grant, P Mishra, N Nilubol
Frontiers in immunology 2021
Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment
S Aoyama, R Nakagawa, S Nemoto, P Perez-Villarroel, JJ Mulé, AW Mailloux
Journal for ImmunoTherapy of Cancer 2021
Multiple Autonomous Cell Death Suppression Strategies Ensure Cytomegalovirus Fitness
P Mandal, LN Nagrani, L Hernandez, AL McCormick, CP Dillon, HS Koehler, L Roback, ES Alnemri, DR Green, ES Mocarski
Viruses 2021
Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice
SH Lee, SY Cho, Y Yoon, C Park, J Sohn, JJ Jeong, BN Jeon, M Jang, C An, S Lee, YY Kim, G Kim, S Kim, Y Kim, GB Lee, EJ Lee, SG Kim, HS Kim, Y Kim, H Kim, HS Yang, S Kim, S Kim, H Chung, MH Moon, MH Nam, JY Kwon, S Won, JS Park, GM Weinstock, C Lee, KW Yoon, H Park
Nature Microbiology 2021
Turning ‘Cold’ tumors ‘Hot’: immunotherapies in sarcoma
J Rytlewski, MM Milhem, V Monga
Annals of translational medicine 2021
Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response
M Vienne, M Etiennot, B Escalière, J Galluso, L Spinelli, S Guia, A Fenis, E Vivier, YM Kerdiles
Frontiers in immunology 2021
YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango
D Matthaios, M Tolia, D Mauri, K Kamposioras, M Karamouzis
Biomedicines 2021
Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer
P Czajka-Francuz, S Cisoń-Jurek, A Czajka, M Kozaczka, J Wojnar, J Chudek, T Francuz
International journal of molecular sciences 2021
Multi-panel mass cytometry reveals anti-PD1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes
Won Jin Ho, Mark Yarchoan, Soren Charmsaz, Rebecca M. Munday, Ludmila Danilova, Marcelo B. Sztein, Elana J Fertig, Elizabeth M. Jaffee
JCI Insight 2020
Autocrine IL6-Mediated Activation of the STAT3–DNMT Axis Silences the TNFα–RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells
AD Smith, C Lu, D Payne, AV Paschall, JD Klement, PS Redd, ML Ibrahim, D Yang, Q Han, Z Liu, H Shi, TJ Hartney, A Nayak-Kapoor, K Liu
Cancer research 2020
The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure
A Chauhan, L Sheriff, MT Hussain, GJ Webb, DA Patten, EL Shepherd, R Shaw, CJ Weston, D Haldar, S Bourke, R Bhandari, S Watson, DH Adams, SP Watson, PF Lalor
Nature Communications 2020
Surgical trauma‐induced immunosuppression in cancer: Recent advances and the potential therapies
F Tang, Y Tie, C Tu, X Wei
Clinical and Translational Medicine 2020
The Engagement Between MDSCs and Metastases: Partners in Crime
R Trovato, S Canè, V Petrova, S Sartoris, S Ugel, FD Sanctis
Frontiers in Oncology 2020
Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms
A Grohová, K Dáňová, I Adkins, Z Šumník, L Petruželková, B Obermannová, S Koloušková, R Špíšek, L Palová-Jelínková, V Taneja
PloS one 2020
Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment
S Deng, MJ Clowers, WV Velasco, M Ramos-Castaneda, SJ Moghaddam
Frontiers in Oncology 2020
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
MF Mercogliano, S Bruni, PV Elizalde, R Schillaci
Frontiers in Oncology 2020
HBV‐specific CD8 T cells present higher TNF‐α expression but lower cytotoxicity in hepatocellular carcinoma
L Zhao, Y Jin, C Yang, C Li
Clinical & Experimental Immunology 2020
Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
HX Lim, TS Kim, CL Poh
International journal of molecular sciences 2020
Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors
Y Zhang, X Guan, P Jiang
Frontiers in immunology 2020
Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection
F Tang, Y Tie, W Hong, Y Wei, C Tu, X Wei
Annals of Surgical Oncology 2020
Location First: Targeting Acute Myeloid Leukemia Within Its Niche
A Pievani, M Biondi, C Tomasoni, A Biondi, M Serafini
Journal of Clinical Medicine 2020
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy
E Lebegge, SM Arnouk, PM Bardet, M Kiss, G Raes, JA Ginderachter
Frontiers in immunology 2020
A20: a master regulator of arthritis
Y Wu, X He, N Huang, J Yu, B Shao
Arthritis Research & Therapy 2020
Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression Microenvironment
C Cheng, Q Shou, J Lang, L Jin, X Liu, D Tang, Z Yang, H Fu
Frontiers in pharmacology 2020
TGF-β Enhances the Anti-inflammatory Effect of Tumor- Infiltrating CD33+11b+HLA-DR Myeloid-Derived Suppressor Cells in Gastric Cancer: A Possible Relation to MicroRNA-494
M Moaaz, H Lotfy, B Elsherbini, M Motawea, G Fadali
Asian Pacific Journal of Cancer Prevention 2020
Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality
N Moradian, M Gouravani, MA Salehi, A Heidari, M Shafeghat, MR Hamblin, N Rezaei
European cytokine network 2020
Impact of inflammation and immunotherapy in renal cell carcinoma (Review)
J Shi, K Wang, Z Xiong, C Yuan, C Wang, Q Cao, H Yu, X Meng, K Xie, Z Cheng, H Yang, K Chen, X Zhang
Oncology Letters 2020
TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP
J Knop, LM Spilgies, S Rufli, R Reinhart, L Vasilikos, M Yabal, E Crowley, PJ Jost, RA Marsh, H Wajant, MD Robinson, T Kaufmann, WW Wong
Cell Death and Disease 2019
Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells
W Gao, X Zhang, W Yang, D Dou, H Zhang, Y Tang, W Zhong, J Meng, Y Bai, Y Liu, L Yang, S Chen, H Liu, C Yang, T Sun
Journal for ImmunoTherapy of Cancer 2019
Hypoxic Regulation of Neutrophils in Cancer
D Triner, YM Shah
International journal of molecular sciences 2019
Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer
H Wajant, A Beilhack
Frontiers in immunology 2019
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
O Herrmann, MK Kuepper, M Bütow, IG Costa, I Appelmann, F Beier, T Luedde, T Braunschweig, S Koschmieder, TH Brümmendorf, M Schemionek
BMC Cancer 2019
The TNF Paradox in Cancer Progression and Immunotherapy
A Montfort, C Colacios, T Levade, N Andrieu-Abadie, N Meyer, B Ségui
Frontiers in immunology 2019
CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3
X Han, H Shi, Y Sun, C Shang, T Luan, D Wang, X Zeng, X Ba
Cell Death and Disease 2019
Myeloid cell TNFR1 signaling dependent liver injury and inflammation upon BCG infection
L Chavez-Galan, D Vesin, G Blaser, H Uysal, S Benmerzoug, S Rose, B Ryffel, VF Quesniaux, I Garcia
Scientific Reports 2019
Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer
T Chanier, P Chames
Antibodies 2019
The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors
M Kreidieh, YH Zeidan, A Shamseddine
Journal of Oncology 2019
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation
J Zhou, S Huang, Z Wang, J Huang, L Xu, X Tang, YY Wan, Q Li, AL Symonds, H Long, B Zhu
Nature Communications 2019
Lipid droplet‐dependent fatty acid metabolism controls the immune suppressive phenotype of tumor‐associated macrophages
H Wu, Y Han, YR Sillke, H Deng, S Siddiqui, C Treese, F Schmidt, M Friedrich, J Keye, J Wan, Y Qin, AA Kühl, Z Qin, B Siegmund, R Glauben
EMBO Molecular Medicine 2019
Theranostics in immuno-oncology using nanobody derivatives
Q Lecocq, YD Vlaeminck, H Hanssens, M D'Huyvetter, G Raes, C Goyvaerts, M Keyaerts, N Devoogdt, K Breckpot
Theranostics 2019
c-FLIP, a Novel Biomarker for Cancer Prognosis, Immunosuppression, Alzheimer's Disease, Chronic Obstructive Pulmonary Disease (COPD), and a Rationale Therapeutic Target
AR Safa, K Kamocki, MR Saadatzadeh, K Bijangi-Vishehsaraei
Biomarkers journal 2019
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
BL Salomon, M Leclerc, J Tosello, E Ronin, E Piaggio, JL Cohen
Frontiers in immunology 2018
S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4–ERK1/2 Signaling
Q Li, C Dai, R Xue, P Wang, L Chen, Y Han, U Erben, Z Qin
Frontiers in immunology 2018
Transmembrane TNF and Partially TNFR1 Regulate TNFR2 Expression and Control Inflammation in Mycobacterial-Induced Pleurisy
H Uysal, L Chavez-Galan, D Vesin, G Blaser, M Benkhoucha, B Ryffel, V Quesniaux, I Garcia
International journal of molecular sciences 2018
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer
Y Nie, J He, H Shirota, AL Trivett, D Yang, DM Klinman, JJ Oppenheim, X Chen
Science signaling 2018
Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult:
TJ Loftus, AM Mohr, LL Moldawer
Current Opinion in Hematology 2018
Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
A Dorhoi, ND Plessis
Frontiers in immunology 2018
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
S Ostrand-Rosenberg, C Fenselau
Journal of immunology (Baltimore, Md. : 1950) 2018
Chronic Inflammation Contributes to Tumor Growth: Possible Role of l-Selectin-Expressing Myeloid-Derived Suppressor Cells (MDSCs)
YV Perfilyeva, N Abdolla, YO Ostapchuk, R Tleulieva, VC Krasnoshtanov, AV Perfilyeva, NN Belyaev
Inflammation 2018
Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses
B Özkan, H Lim, SG Park
International journal of molecular sciences 2018
Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells
O Ticha, L Moos, H Wajant, I Bekeredjian-Ding
Frontiers in immunology 2018
TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders
F Shaikh, J He, P Bhadra, X Chen, SW Siu
Frontiers in immunology 2018
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
H Zou, R Li, H Hu, Y Hu, X Chen
Frontiers in immunology 2018
Oxaliplatin regulates myeloid-derived suppressor cell-mediated immunosuppression via downregulation of nuclear factor-κB signaling
NR Kim, YJ Kim
Cancer Medicine 2018
Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages
D Bayik, D Tross, DM Klinman
Frontiers in immunology 2018
Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell–Independent Tumor Proliferation
Q Zeng, J Fu, M Korrer, M Gorbounov, PJ Murray, D Pardoll, DL Masica, YJ Kim
Cancer immunology research 2018
The Role of Tumor Necrosis Factor Alpha (TNFα) in Hearing Loss and Vestibular Schwannomas
Y Ren, KM Stankovic
Current Otorhinolaryngology Reports 2018
TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
Y Sheng, F Li, Z Qin
Frontiers in immunology 2018
Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer
R Xiao, CT Allen, L Tran, P Patel, SJ Park, Z Chen, CV Waes, NC Schmitt
OncoImmunology 2018
Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice
V Lamontain, T Schmid, D Weber-Steffens, D Zeller, Z Jenei-Lanzl, H Wajant, RH Straub, DN Männel
Cellular and Molecular Immunology 2018
TNFR1 Signaling Contributes to T Cell Anergy During Staphylococcus aureus Sepsis
C Ledo, CD Gonzalez, CV Poncini, M Mollerach, MI Gómez
Frontiers in Cellular and Infection Microbiology 2018
The Key Role of TNF-TNFR2 Interactions in the Modulation of Allergic Inflammation: A Review
S Ahmad, NA Azid, JC Boer, JK Lim, X Chen, M Plebanski, R Mohamud
Frontiers in immunology 2018
Silicosis and lung cancer: current perspectives
T Sato, T Shimosato, DM Klinman
Lung Cancer: Targets and Therapy 2018
Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells
VK Clements, T Long, R Long, C Figley, DM Smith, S Ostrand-Rosenberg
Journal of leukocyte biology 2018
Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
J Zhu, PF Petit, BJ den Eynde
Cancer Immunology, Immunotherapy 2018
S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity
J Zhang, K Song, J Wang, Y Li, S Liu, C Dai, L Chen, S Wang, Z Qin
OncoImmunology 2017
Radiotherapy and immunotherapy: a beneficial liaison?
RR Weichselbaum, H Liang, L Deng, YX Fu
Nature Reviews Clinical Oncology 2017
TNFR2: The new Treg switch?
JL Cohen, KJ Wood
OncoImmunology 2017
Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy
L Chavez-Galan, D Vesin, H Uysal, G Blaser, M Benkhoucha, B Ryffel, VF Quesniaux, I Garcia
Frontiers in immunology 2017
The role of the immune system in neurofibromatosis type 1-associated nervous system tumors
S Karmakar, KM Reilly
CNS Oncology 2017
STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
WY Kuo, L Hwu, CY Wu, JS Lee, CW Chang, RS Liu
Theranostics 2017
Pak2 regulates myeloid-derived suppressor cell development in mice
Y Zeng, S Hahn, J Stokes, EA Hoffman, M Schmelz, M Proytcheva, J Chernoff, E Katsanis
Blood Advances 2017
Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
G Yang, W Shen, Y zhang, M Liu, L Zhang, Q Liu, H Lu, J Bo
Oncotarget 2017
PRKCI promotes immune suppression in ovarian cancer
S Sarkar, CA Bristow, P Dey, K Rai, R Perets, A Ramirez-Cardenas, S Malasi, E Huang-Hobbs, M Haemmerle, SY Wu, M McGuire, A Protopopov, S Jiang, JF Liu, MS Hirsch, Q Chang, AJ Lazar, AK Sood, R Drapkin, R DePinho, G Draetta, L Chin
Genes & development 2017
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
AR Pyzer, D Stroopinsky, H Rajabi, A Washington, A Tagde, M Coll, J Fung, MP Bryant, L Cole, K Palmer, P Somaiya, RK Leaf, M Nahas, A Apel, S Jain, M McMasters, L Mendez, J Levine, R Joyce, J Arnason, PP Pandolfi, D Kufe, J Rosenblatt, D Avigan
Blood 2017
Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation
T Schmid, L Falter, S Weber, N Müller, K Molitor, D Zeller, D Weber-Steffens, T Hehlgans, H Wajant, S Mostböck, DN Männel
Frontiers in immunology 2017
Identifying tumor promoting genomic alterations in tumor-associated fibroblasts via retrovirus-insertional mutagenesis
L Rong, Y Bian, S Liu, X Liu, X Li, H Liu, J Zhou, J Peng, H Zhang, H Chen, Z Qin
Oncotarget 2017
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
SL Jian, WW Chen, YC Su, YW Su, TH Chuang, SC Hsu, LR Huang
Cell Death and Disease 2017
Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells
H Wu, C Weidinger, F Schmidt, J Keye, M Friedrich, C Yerinde, G Willimsky, Z Qin, B Siegmund, R Glauben
Scientific Reports 2017
Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression
RJ Seager, C Hajal, F Spill, RD Kamm, MH Zaman
Convergent Science Physical Oncology 2017
Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
BH Koehn, BR Blazar
Journal of leukocyte biology 2017
Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation:
NN Scheff, Y Ye, A Bhattacharya, J MacRae, DN Hickman, AK Sharma, JC Dolan, BL Schmidt
PAIN 2017
Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance
RA Sierra, J Trillo-Tinoco, E Mohamed, L Yu, BR Achyut, A Arbab, JW Bradford, BA Osborne, L Miele, PC Rodriguez
Cancer research 2017
Forward and Reverse Signaling Mediated by Transmembrane Tumor Necrosis Factor-Alpha and TNF Receptor 2: Potential Roles in an Immunosuppressive Tumor Microenvironment
Y Qu, G Zhao, H Li
Frontiers in immunology 2017
Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse
RL Konger, E Derr-Yellin, JB Travers, JA Ocana, RP Sahu
Oncotarget 2017
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
F Bertrand, A Montfort, E Marcheteau, C Imbert, J Gilhodes, T Filleron, P Rochaix, N Andrieu-Abadie, T Levade, N Meyer, C Colacios, B Ségui
Nature Communications 2017
Hypoxia: A central link between inflammation and cancer
Daniel Triner, Yatrik Shah
Journal of Clinical Investigation 2016
Cytokine-Induced Modulation of Colorectal Cancer
LF Mager, MH Wasmer, TT Rau, P Krebs
Frontiers in Oncology 2016
Esophageal Expression of Active IκB Kinase-β in Mice Up-Regulates Tumor Necrosis Factor and Granulocyte-Macrophage Colony-Stimulating Factor, Promoting Inflammation and Angiogenesis
MP Tétreault, D Weinblatt, JD Ciolino, AJ Klein-Szanto, BK Sackey, CT Victor, T Karakasheva, V Teal, JP Katz
Gastroenterology 2016
Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
AW Ku, JB Muhitch, CA Powers, M Diehl, M Kim, DT Fisher, AP Sharda, VK Clements, K O'Loughlin, H Minderman, MN Messmer, J Ma, JJ Skitzki, DA Steeber, B Walcheck, S Ostrand-Rosenberg, SI Abrams, SS Evans
eLife 2016
Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma
S Murakami, D Shahbazian, R Surana, W Zhang, H Chen, GT Graham, SM White, LM Weiner, C Yi
Oncogene 2016
Tumor Necrosis Factor Links Chronic Obstructive Pulmonary Disease and K-ras Mutant Lung Cancer through Induction of an Immunosuppressive Pro-Tumor Microenvironment
L Gong, MS Caetano, AM Cumpian, S Daliri, AG Flores, SH Chang, CE Ochoa, CM Evans, Z Yu, SJ Moghaddam
OncoImmunology 2016
TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation
KS Atretkhany, MA Nosenko, VS Gogoleva, RV Zvartsev, Z Qin, SA Nedospasov, MS Drutskaya
Frontiers in immunology 2016
Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
A Sobo-Vujanovic, L Vujanovic, AB DeLeo, F Concha-Benavente, RL Ferris, Y Lin, NL Vujanovic
Cancer immunology research 2016
TNF activity and T cells
AK Mehta, DT Gracias, M Croft
Cytokine 2016
High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy
KH Parker, LA Horn, S Ostrand-Rosenberg
Journal of leukocyte biology 2016
Circulating CD14 + HLA-DR -/low myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease
J Yin, C Wang, M Huang, X Mao, J Zhou, Y Zhang
Cancer Medicine 2016
Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancer
C Zhang, S Wang, Y Liu, C Yang
Oncotarget 2016
Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells
MO Kilinc, K Ehrig, M Pessian, BR Minev, AA Szalay
Journal of Translational Medicine 2016
Myeloid-Derived Suppressor Cells in Bacterial Infections
M Ost, A Singh, A Peschel, R Mehling, N Rieber, D Hartl
Frontiers in Cellular and Infection Microbiology 2016
Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner
X Xu, Q Meng, U Erben, P Wang, R Glauben, AA Kühl, H Wu, CW Ma, M Hu, Y Wang, W Sun, J Jia, X Wu, W Chen, B Siegmund, Z Qin
Cellular and Molecular Immunology 2016
Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption
SE Dross, PV Munson, SE Kim, DL Bratt, HC Tunggal, AL Gervassi, DH Fuller, H Horton
Journal of immunology (Baltimore, Md. : 1950) 2016
Myeloid-derived suppressor cells in the tumor microenvironment: things are not always what they seem
Douglas Marvel, Dmitry I. Gabrilovich
Journal of Clinical Investigation 2015
Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells
P Xiao, X Wan, B Cui, Y Liu, C Qiu, J Rong, M Zheng, Y Song, L Chen, J He, Q Tan, X Wang, X Shao, Y Liu, X Cao, Q Wang
OncoImmunology 2015
Transcriptional regulation of myeloid-derived suppressor cells
T Condamine, J Mastio, DI Gabrilovich
Journal of leukocyte biology 2015
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
GD Kalliolias, LB Ivashkiv
Nature Reviews Rheumatology 2015
CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
QQ Zhang, XW Hu, YL Liu, ZJ Ye, YH Gui, DL Zhou, CL Qi, XD He, H Wang, LJ Wang
Scientific Reports 2015
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
T Condamine, I Ramachandran, JI Youn, DI Gabrilovich
Annual Review of Medicine 2015
Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
H Katoh, M Watanabe
Mediators of Inflammation 2015
SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells
H Yu, Y Liu, BC McFarland, JS Deshane, DR Hurst, S Ponnazhagan, EN Benveniste, H Qin
Cancer immunology research 2015
Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1
L Puimege, FV Hauwermeiren, S Steeland, SV Ryckeghem, J Vandewalle, S Lodens, L Dejager, S Vandevyver, J Staelens, S Timmermans, RE Vandenbroucke, C Libert
EMBO Molecular Medicine 2015
Differential Induction of Ly6G and Ly6C Positive Myeloid Derived Suppressor Cells in Chronic Kidney and Liver Inflammation and Fibrosis
B Höchst, J Mikulec, T Baccega, C Metzger, M Welz, J Peusquens, F Tacke, P Knolle, C Kurts, L Diehl, I Ludwig-Portugall, CH Kim
PloS one 2015
Targeting TNFα as a novel strategy to enhance CD8+ T cell-dependent immune response in melanoma?
F Bertrand, J Rochotte, C Colacios, A Montfort, N Andrieu-Abadie, T Levade, H Benoist, B Ségui
OncoImmunology 2015
Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia
H Sun, Y Li, Z Zhang, Y Ju, L Li, B Zhang, B Liu
International Journal of Hematology 2015
Irradiation and anti-B7-H1 provide synergistic treatment effects in murine cancer
liufu deng, Hua Liang, byron burnette, michael beckett, Thomas Darga, Ralph Weichselbaum, Yangxin Fu
Journal of Clinical Investigation 2014
ER stress response regulates the fate of myeloid-derived suppressor cells through TRAIL receptors mediated apoptosis
Thomas Condamine, Vinit Kumar, Indu Ramachandran, Je-In Youn, Esteban Celis, Niklas Finnberg, Wafik El-Deiry, Rafael Winograd, Robert Vonderheide, Nickolas English, Stella Knight, Hideo Yagita, Judith McCaffrey, Scott Antonia, Neil Hockstein, Robert Witt, Gregory Masters, Thomas Bauer, Dmitry I. Gabrilovich
Journal of Clinical Investigation 2014
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
MK Gleason, JA Ross, ED Warlick, TC Lund, MR Verneris, A Wiernik, S Spellman, MD Haagenson, AJ Lenvik, MR Litzow, PK Epling-Burnette, BR Blazar, LM Weiner, DJ Weisdorf, DA Vallera, JS Miller
Blood 2014
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
P Wu, D Wu, C Ni, J Ye, W Chen, G Hu, Z Wang, C Wang, Z Zhang, W Xia, Z Chen, K Wang, T Zhang, J Xu, Y Han, T Zhang, X Wu, J Wang, W Gong, S Zheng, F Qiu, J Yan, J Huang
Immunity 2014
Novel Role for Tumor-Induced Expansion of Myeloid-Derived Cells in Cancer Cachexia
AG Cuenca, AL Cuenca, RD Winfield, DN Joiner, L Gentile, MJ Delano, KM Kelly-Scumpia, PO Scumpia, MK Matheny, PJ Scarpace, L Vila, PA Efron, DM LaFace, LL Moldawer
Journal of immunology (Baltimore, Md. : 1950) 2014
Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways
JM Haverkamp, AM Smith, R Weinlich, CP Dillon, JE Qualls, G Neale, B Koss, Y Kim, V Bronte, MJ Herold, DR Green, JT Opferman, PJ Murray
Immunity 2014
Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity: TNFR2 and MDSC
J Polz, A Remke, S Weber, D Schmidt, D Weber-Steffens, A Pietryga-Krieger, N Müller, U Ritter, S Mostböck, DN Männel
Immunity, Inflammation and Disease 2014
Downregulation of CD40 expression contributes to the accumulation of myeloid-derived suppressor cells in gastric tumors
J Shen, X Chen, Z Wang, G Zhang, W Chen
Oncology Letters 2014
Role of myeloid-derived suppressor cells in autoimmune disease
KR Crook
World Journal of Immunology 2014
True Grit: Programmed Necrosis in Antiviral Host Defense, Inflammation, and Immunogenicity
ES Mocarski, WJ Kaiser, D Livingston-Rosanoff, JW Upton, LP Daley-Bauer
Journal of immunology (Baltimore, Md. : 1950) 2014
Soluble, but Not Transmembrane, TNF-  Is Required during Influenza Infection To Limit the Magnitude of Immune Responses and the Extent of Immunopathology
MP DeBerge, KH Ely, RI Enelow
Journal of immunology (Baltimore, Md. : 1950) 2014
Intratumoral CD4 + T Lymphodepletion Sensitizes Poorly Immunogenic Melanomas to Immunotherapy with an OX40 Agonist
S Fujiwara, H Nagai, N Shimoura, S Oniki, T Yoshimoto, C Nishigori
Journal of Investigative Dermatology 2014
Myeloid-derived suppressor cell development is regulated by a STAT-IRF-8 Axis
Jeremy Waight, Colleen Netherby, Mary Hensen, Austin Miller, Qiang Hu, Song Liu, Paul Bogner, Matthew Farren, Kelvin Lee, Kebin Liu, Scott Abrams
Journal of Clinical Investigation 2013
Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly
P Serafini
Immunologic Research 2013
CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
H Katoh, D Wang, T Daikoku, H Sun, SK Dey, RN DuBois
Cancer Cell 2013
Viral modulation of programmed necrosis
WJ Kaiser, JW Upton, ES Mocarski
Current Opinion in Virology 2013
TNFR-1 on tumor cells contributes to the sensitivity of fibrosarcoma to chemotherapy
J Deng, X Zhao, L Rong, X Li, X Liu, Z Qin
Protein & Cell 2013
Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?
C Goh, S Narayanan, YS Hahn
Immunological Reviews 2013
Chronic inflammation and cancer: suppressing the suppressors
Baniyash M, Sade-Feldman M, Kanterman J
Cancer Immunology, Immunotherapy 2013
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 1 X users
Referenced in 19 patents
On 1 Facebook pages
212 readers on Mendeley
See more details